Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sage Institute for Psychedelic Therapy is a California nonprofit mental health organization focused on accessible psychotherapy, psychedelic-assisted therapy, therapist training, and community-centered research. The organization operates a sliding-scale clinic in Oakland and emphasizes culturally responsive care for underserved and systematically oppressed communities. Public descriptions indicate services that include psychotherapy, ketamine therapy, integration support, and professional training in psychedelic therapy. It appears to function primarily as a care delivery, training, and applied research organization rather than a drug-development biotech company. For a biotech analyst, Sage Institute is best understood as a nonprofit psychedelic-therapy provider and training institute in behavioral health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sage Institute for Psychedelic Therapy.